Al Robichaud
Private Equity Investor bei Cure Ventures Management LP
Vermögen: 3 Mio $ am 31.03.2024
Profil
Derzeit ist Albert J. Robichaud Chief Scientific Officer von SAGE Therapeutics, Inc. Dr. Robichaud war zuvor als VP-Chemistry & Pharmacokinetic Sciences bei Lundbeck USA Inc. und als Senior Director & Head-Neuroscience Discovery bei Wyeth Research tätig. Albert J. Robichaud erwarb einen Bachelor-Abschluss am Rensselaer Polytechnic Institute und einen Doktortitel an der University of California, Irvine.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
SAGE THERAPEUTICS, INC.
0,24% | 13.02.2023 | 145 553 ( 0,24% ) | 3 Mio $ | 31.03.2024 |
Aktive Positionen von Al Robichaud
Unternehmen | Position | Beginn |
---|---|---|
Cure Ventures Management LP
Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 01.01.2024 |
Ehemalige bekannte Positionen von Al Robichaud
Unternehmen | Position | Ende |
---|---|---|
SAGE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 09.10.2023 |
Lundbeck, Inc.
Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck, Inc. is a pharmaceutical company that produces pharmaceutical preparations. The private company is based in Paramus, NJ. The company was founded by Jeffrey S. Aronin. | Corporate Officer/Principal | 01.01.2011 |
Wyeth Research
Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The private company is based in Cambridge, MA. | Director/Board Member | 01.01.2010 |
Lundbeck USA Inc. | Corporate Officer/Principal | - |
Ausbildung von Al Robichaud
Rensselaer Polytechnic Institute | Undergraduate Degree |
University of California, Irvine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SAGE THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Wyeth Research
Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The private company is based in Cambridge, MA. | Commercial Services |
Lundbeck, Inc.
Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck, Inc. is a pharmaceutical company that produces pharmaceutical preparations. The private company is based in Paramus, NJ. The company was founded by Jeffrey S. Aronin. | Health Technology |
Lundbeck USA Inc. | |
Cure Ventures Management LP
Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Finance |